| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ELI LILLY & Co | EVP & Pres., Lilly Oncology | Common Stock | 11.8K | $10.7M | $906.13 | Oct 31, 2024 | Direct |
| ELI LILLY & Co | EVP & Pres., Lilly Oncology | Common Stock | 4.34K | $3.93M | $906.13 | Oct 31, 2024 | Van Naarden Family Trust |
| ELI LILLY & Co | EVP & Pres., Lilly Oncology | Common Stock | 4.3K | $3.9M | $906.13 | Oct 31, 2024 | By spouse |
| ELI LILLY & Co | EVP & Pres., Lilly Oncology | Restricted Stock Unit | 3.02K | $2.23M | $737.26 | Feb 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & Co | Oct 31, 2024 | 1 | $0 | 4 | Nov 1, 2024 | EVP & Pres., Lilly Oncology |
| LLY | ELI LILLY & Co | Feb 12, 2024 | 2 | $1.75M | 4 | Feb 14, 2024 | EVP & Pres., Loxo@Lilly |
| LLY | ELI LILLY & Co | Feb 1, 2024 | 3 | -$1.09M | 4 | Feb 2, 2024 | EVP & Pres., Loxo@Lilly |
| LLY | ELI LILLY & Co | Feb 16, 2023 | 3 | -$440K | 4 | Feb 21, 2023 | EVP and CEO Loxo@Lilly |
| LLY | ELI LILLY & Co | Feb 10, 2023 | 1 | $831K | 4 | Feb 14, 2023 | EVP and CEO Loxo@Lilly |
| LLY | ELI LILLY & Co | Feb 16, 2022 | 3 | -$533K | 4 | Feb 17, 2022 | SVP, CEO LoxoONC, Pres LlyONC |
| LLY | ELI LILLY & Co | Dec 28, 2021 | 1 | $0 | 4 | Dec 30, 2021 | SVP, CEO LoxoONC, Pres LlyONC |
| LLY | ELI LILLY & Co | Sep 5, 2021 | 0 | $0 | 3 | Sep 7, 2021 | SVP, CEO LoxoONC, Pres LlyONC |